StockData
BYAHNasdaqSoap, Detergents, Cleang Preparations, Perfumes, CosmeticsFiscal year ends October 31

Park Ha Biological Technology Co., Ltd.

Financials through fiscal 2025, year ended Oct 31, 2025Last filing: 20-F on Mar 2, 2026
$2.25+0.05 (+2.27%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Park Ha Biological Technology statistics

Financials through Apr 30, 2026, price as of Oct 19, 2026, median of Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics companies for comparison

Valuation

MeasurePark Ha Biological TechnologyIndustry median
Market Cap$1.52M$166.30M
Enterprise Value-$4.13M$88.19M
PS Ratio0.603.65
PB Ratio0.282.03
P/TBV Ratio0.282.29
P/OCF Ratio17.7612.98

Enterprise value

MeasurePark Ha Biological TechnologyIndustry median
EV / Sales-1.642.51

Income (trailing twelve months)

MeasurePark Ha Biological TechnologyIndustry median
Revenue$2.52M$58.34M
Gross Profit$2.38M$105.94M
Operating Income-$24.15M-$21.40M
Pretax Income-$24.08M-$14.34M
Net Income-$24.36M-$22.46M
EBITDA-$24.04M-$16.91M
EPS (Diluted)-$41.38-$0.83

Margins

MeasurePark Ha Biological TechnologyIndustry median
Gross Margin94.4%52.9%
Operating Margin-956.5%-44.0%
Pretax Margin-953.9%-13.3%
Profit Margin-965.0%-40.2%
EBITDA Margin-952.1%-30.2%
FCF Margin-0.12%-9.27%

Returns

MeasurePark Ha Biological TechnologyIndustry median
Return on Equity (ROE)-505.6%-53.2%
Return on Assets (ROA)-366.6%-40.9%
Return on Invested Capital (ROIC)-1451.4%-32.4%
Return on Capital Employed (ROCE)-443.5%-38.1%

Growth

MeasurePark Ha Biological TechnologyIndustry median
Revenue Growth (YoY)6.00%5.96%
Net Income Growth (YoY)-5191.3%-35.2%
EPS Growth (YoY)-4410.4%-26.2%
FCF Growth (YoY)-100.3%2.34%
Revenue Growth (3Y CAGR)9.57%2.25%

Balance sheet

MeasurePark Ha Biological TechnologyIndustry median
Cash & Short-Term Investments$5.66M$61.43M
Net Cash (Debt)$5.66M$15.35M
Net Cash Per Share$8.35$0.66
Equity (Book Value)$5.39M$49.09M
Book Value Per Share$7.95$1.37
Tangible Book Value$5.38M$23.52M
Working Capital$4.77M$76.81M

Financial position

MeasurePark Ha Biological TechnologyIndustry median
Current Ratio3.363.34
Quick Ratio2.812.44
Interest Coverage-588998.00-6.26

Cash flow (trailing twelve months)

MeasurePark Ha Biological TechnologyIndustry median
Operating Cash Flow$85.85K-$12.35M
Capital Expenditures-$88.83K-$1.08M
Free Cash Flow-$2.97K-$20.22M
FCF Per Share-$0.00-$0.42

Efficiency

MeasurePark Ha Biological TechnologyIndustry median
Asset Turnover0.380.39
Inventory Turnover1.682.70
Revenue Per Employee$100.99K$404.87K
Profits Per Employee-$974.59K-$703.34K
Employee Count2574

Dividends and yields

MeasurePark Ha Biological TechnologyIndustry median
Earnings Yield-1598.4%-23.3%
FCF Yield-0.20%-8.72%
Buyback Yield-280.6%-0.59%
Shareholder Yield-280.6%0.00%

Shares

MeasurePark Ha Biological TechnologyIndustry median
Shares Outstanding677,48858,127,000
Shares Change (YoY)17.8%10.9%

Taxes

MeasurePark Ha Biological TechnologyIndustry median
Income Tax$280.65K$79.87K

Scores

MeasurePark Ha Biological TechnologyIndustry median
Altman Z-Score-13.84-0.22
Piotroski F-Score54
Beneish M-Score-25.24-2.62

Calculated by StockData from Park Ha Biological Technology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.